Stallergenes Greer and Alyatec announced that they have entered into a collaboration to advance precision medicine in AIT. With this collaboration, Stallergenes Greer aims to strengthen its precision medicine-based approach and the management of patients with allergies by expanding its knowledge of allergy pathophysiology and endotypes, AIT mode of action and clinical validation. This research collaboration brings together the longstanding expertise of Stallergenes Greer in AIT and Alyatec’s competencies in research and clinical services as well as its technology, including a new generation environmental exposure chamber.